Supernus Pharmaceuticals reported $370.38M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adamas Pharmaceuticals ADMS:US 4.17M 125.57M
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
Ani Pharmaceuticals ANIP:US $ 204.71M 21.28M
Aphria Inc APH:CN C$ 928.67M 381.15M
Aurora Cannabis Inc ACB:CN 480.92M 12.46M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Canopy Growth Corp WEED:CN C$ 1.69B 45.4M
Cara Therapeutics CARA:US $ 0 0
Corcept Therapeutics CORT:US $ 0M 0M
Eisai 4523:JP Y 92683M 2790M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Endo International Ordinary Shares ENDP:US $ 8304.11M 3.58M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2576.44M 2.07M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Lannett LCI:US $ 590.68M 20.02M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Pacira Pharmaceuticals PCRX:US $ 475.39M 6.4M
Perrigo Ordinary Shares PRGO:US $ 3555.9M 5.2M
Revance Therapeutics RVNC:US $ 280M 0.31M
Supernus Pharmaceuticals SUPN:US $ 370.38M 18.83M
Teva Pharmaceutical Industries TEVA:US $ 25132M 147M
United Therapeutics UTHR:US $ 800M 0M
Xeris Pharmaceuticals Inc XERS:US $ 87.48M 206K